β-catenin as a prognostic factor for prostate cancer (PCa)

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Prostate cancer prognosis is challenging, with treatment failure linked to local infiltration and distant metastases.
• Cancer cell adhesion and migration are critical for metastasis formation.
• Beta-catenin (β-catenin) plays a significant role in the pathogenesis of various cancers and benign conditions.

Purpose of the Study:

• To determine the predictive value of β-catenin immunoexpression in prostate cancer.
• To analyze the prognostic significance of histopathological features.
• To assess the relationship between β-catenin immunoreactivity and tumor microscopic appearance.

Main Methods:

• Analysis of transrectal core biopsies from 102 prostate cancer patients.
• Immunoexpression assessment of β-catenin.
• Statistical analysis including Chi-squared test, Kaplan-Meier curves, and Cox proportional hazard regression.

Main Results:

• Impaired location and strength of β-catenin immunoexpression observed in prostate cancer compared to normal epithelium.
• Significant correlation between β-catenin immunoreactivity and histopathological features was assessed.

Conclusions:

• Disorders in β-catenin immunoexpression in prostate cancer cells indicate a high risk of mortality due to tumor progression.
• These findings underscore the necessity for immediate treatment strategies in patients with altered β-catenin expression.